Otamixaban

CAS No. 193153-04-7

Otamixaban( FXV-673 )

Catalog No. M13026 CAS No. 193153-04-7

A potent and selective factor Xa (FXa) inhibitor with Ki of 0.4 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 202 Get Quote
50MG 896 Get Quote
100MG 1341 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Otamixaban
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent and selective factor Xa (FXa) inhibitor with Ki of 0.4 nM.
  • Description
    A potent and selective factor Xa (FXa) inhibitor with Ki of 0.4 nM; shows >1,000-fold selectivity over thrombin, activated protein C (aPC), plasmin, and tissue-plasminogen activator (t-PA); dose-dependently prolongs the time to vessel occlusion and inhibits thrombus formation in canine models of thrombosis.Thrombosis Phase 3 Discontinued.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    FXV-673
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Factor Xa
  • Recptor
    Factor Xa
  • Research Area
    Cardiovascular Disease
  • Indication
    Thrombosis

Chemical Information

  • CAS Number
    193153-04-7
  • Formula Weight
    446.4984
  • Molecular Formula
    C25H26N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    C[C@@H](NC(C1=CC=C(C2=CC=[N+]([O-])C=C2)C=C1)=O)[C@@H](CC3=CC=CC(C(N)=N)=C3)C(OC)=O
  • Chemical Name
    Benzenepropanoic acid, 3-(aminoiminomethyl)-.alpha.-[(1R)-1-[[4-(1-oxido-4-pyridinyl)benzoyl]amino]ethyl]-, methyl ester, (.alpha.R)-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Guertin KR, et al. Bioorg Med Chem Lett. 2002 Jun 17;12(12):1671-4. 2. Chu V, et al. Thromb Res. 2001 Aug 15;103(4):309-24. 3. Rebello SS, et al. J Cardiovasc Pharmacol. 2001 Aug;38(2):288-97.
molnova catalog
related products
  • Razaxaban hydrochlor...

    A highly potent, selective, and orally bioavailable factor Xa (FXa) inhibitor with Ki of o.19 nM.

  • EMD-503982

    EMD-503982 is a potential Factor Xa and Factor VIIa inhibitor with potential anticancer and antitumor activity for the study of thromboembolic and neurological disorders.

  • Apixaban

    A highly potent, selective, efficacious, and orally bioavailable inhibitor of factor Xa (FXa) with Ki of 0.08 nM; shows no affinity for thrombin (Ki>3 uM).